Peregrine Pharmaceuticals, Inc.Product Pipeline Review - 2015
Summary
Global Markets Directs, Peregrine Pharmaceuticals, Inc.Product Pipeline Review - 2015, provides an overview of the Peregrine Pharmaceuticals, Inc.s pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of Peregrine Pharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
The report provides brief overview of Peregrine Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of Peregrine Pharmaceuticals, Inc.s human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement
Latest news and deals relating to the Peregrine Pharmaceuticals, Inc.s pipeline products
Reasons to buy
Evaluate Peregrine Pharmaceuticals, Inc.s strategic position with total access to detailed information on its product pipeline
Assess the growth potential of Peregrine Pharmaceuticals, Inc. in its therapy areas of focus
Identify new drug targets and therapeutic classes in the Peregrine Pharmaceuticals, Inc.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of Peregrine Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of Peregrine Pharmaceuticals, Inc.
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
Explore the dormant and discontinued projects of Peregrine Pharmaceuticals, Inc. and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues
Table of Contents
List of Tables 4
List of Figures 4
Peregrine Pharmaceuticals, Inc. Snapshot 5
Peregrine Pharmaceuticals, Inc. Overview 5
Key Information 5
Key Facts 5
Peregrine Pharmaceuticals, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Peregrine Pharmaceuticals, Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Pipeline Products - Out-Licensed Products 12
Out-Licensed Products/Combination Treatment Modalities 13
Peregrine Pharmaceuticals, Inc. - Pipeline Products Glance 14
Peregrine Pharmaceuticals, Inc. - Late Stage Pipeline Products 14
Phase III Products/Combination Treatment Modalities 14
Peregrine Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 15
Phase II Products/Combination Treatment Modalities 15
Phase I Products/Combination Treatment Modalities 16
Peregrine Pharmaceuticals, Inc. - Early Stage Pipeline Products 17
Preclinical Products/Combination Treatment Modalities 17
Discovery Products/Combination Treatment Modalities 18
Peregrine Pharmaceuticals, Inc. - Drug Profiles 19
bavituximab 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
iodine I 131 derlotuximab biotin 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
PGN-632 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Peregrine Pharmaceuticals, Inc. - Pipeline Analysis 27
Peregrine Pharmaceuticals, Inc. - Pipeline Products by Target 27
Peregrine Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 28
Peregrine Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 29
Peregrine Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 30
Peregrine Pharmaceuticals, Inc. - Recent Pipeline Updates 31
Peregrine Pharmaceuticals, Inc. - Dormant Projects 41
Peregrine Pharmaceuticals, Inc. - Discontinued Pipeline Products 42
Discontinued Pipeline Product Profiles 42
bavituximab 42
Oncolym 42
Peregrine Pharmaceuticals, Inc. - Locations And Subsidiaries 43
Head Office 43
Other Locations & Subsidiaries 43
Appendix 44
Methodology 44
Coverage 44
Secondary Research 44
Primary Research 44
Expert Panel Validation 44
Contact Us 44
Disclaimer 45
List of Tables
Peregrine Pharmaceuticals, Inc., Key Information 5
Peregrine Pharmaceuticals, Inc., Key Facts 5
Peregrine Pharmaceuticals, Inc. - Pipeline by Indication, 2015 7
Peregrine Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015 8
Peregrine Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015 9
Peregrine Pharmaceuticals, Inc. - Partnered Products in Pipeline, 2015 10
Peregrine Pharmaceuticals, Inc. - Partnered Products/ Combination Treatment Modalities, 2015 11
Peregrine Pharmaceuticals, Inc. - Out-Licensed Products in Pipeline, 2015 12
Peregrine Pharmaceuticals, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2015 13
Peregrine Pharmaceuticals, Inc. - Phase III, 2015 14
Peregrine Pharmaceuticals, Inc. - Phase II, 2015 15
Peregrine Pharmaceuticals, Inc. - Phase I, 2015 16
Peregrine Pharmaceuticals, Inc. - Preclinical, 2015 17
Peregrine Pharmaceuticals, Inc. - Discovery, 2015 18
Peregrine Pharmaceuticals, Inc. - Pipeline by Target, 2015 27
Peregrine Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2015 28
Peregrine Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2015 29
Peregrine Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2015 30
Peregrine Pharmaceuticals, Inc. - Recent Pipeline Updates, 2015 31
Peregrine Pharmaceuticals, Inc. - Dormant Developmental Projects,2015 41
Peregrine Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2015 42
Peregrine Pharmaceuticals, Inc., Subsidiaries 43
List of Figures
Peregrine Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2015 7
Peregrine Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015 8
Peregrine Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015 9
Peregrine Pharmaceuticals, Inc. - Partnered Products in Pipeline, 2015 10
Peregrine Pharmaceuticals, Inc. - Out-Licensed Products in Pipeline, 2015 12
Peregrine Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2015 27
Peregrine Pharmaceuticals, Inc. - Pipeline by Top 10 Route of Administration, 2015 28
Peregrine Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2015 29
Peregrine Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015 30
